Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $15.0400 (0%) ($14.1600 - $15.3600) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.26% (three month average) | RSI | 46 | Latest Price | $15.0400(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -1.1% a day on average for past five trading days. | Weekly Trend | FOLD advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(54%) IWO(51%) XBI(50%) IWM(47%) IWC(45%) | Factors Impacting FOLD price | FOLD will decline at least -2.13% in a week (0% probabilities). VIXM(-28%) VXX(-14%) UUP(-12%) IYT(-5%) XLC(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.13% (StdDev 4.26%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
Resistance Level | $15.17 | 5 Day Moving Average | $15.44(-2.59%) | 10 Day Moving Average | $15.49(-2.91%) | 20 Day Moving Average | $15.17(-0.86%) | To recent high | -5.3% | To recent low | 50% | Market Cap | $3.884b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |